nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—RRM2—Hydroxyurea—brain cancer	0.325	0.464	CbGbCtD
Gemcitabine—RRM1—Hydroxyurea—brain cancer	0.325	0.464	CbGbCtD
Gemcitabine—ABCC10—Etoposide—brain cancer	0.0455	0.065	CbGbCtD
Gemcitabine—ABCB1—Etoposide—brain cancer	0.00424	0.00605	CbGbCtD
Gemcitabine—CMPK1—hindbrain—brain cancer	0.00233	0.0441	CbGeAlD
Gemcitabine—Azacitidine—DNMT1—brain cancer	0.00195	0.43	CrCbGaD
Gemcitabine—Decitabine—DNMT1—brain cancer	0.0019	0.42	CrCbGaD
Gemcitabine—SLC28A1—endocrine gland—brain cancer	0.00141	0.0267	CbGeAlD
Gemcitabine—CMPK1—brainstem—brain cancer	0.00134	0.0253	CbGeAlD
Gemcitabine—TYMS—Podofilox—Etoposide—brain cancer	0.00128	1	CbGdCrCtD
Gemcitabine—POLD1—gonad—brain cancer	0.00124	0.0235	CbGeAlD
Gemcitabine—CMPK1—telencephalon—brain cancer	0.00119	0.0225	CbGeAlD
Gemcitabine—CMPK1—gonad—brain cancer	0.000991	0.0187	CbGeAlD
Gemcitabine—CMPK1—pituitary gland—brain cancer	0.000967	0.0183	CbGeAlD
Gemcitabine—POLE—gonad—brain cancer	0.000929	0.0176	CbGeAlD
Gemcitabine—POLD1—head—brain cancer	0.000927	0.0175	CbGeAlD
Gemcitabine—POLE—pituitary gland—brain cancer	0.000906	0.0171	CbGeAlD
Gemcitabine—CMPK1—midbrain—brain cancer	0.000853	0.0161	CbGeAlD
Gemcitabine—CDA—endocrine gland—brain cancer	0.000843	0.0159	CbGeAlD
Gemcitabine—CMPK1—spinal cord—brain cancer	0.000832	0.0157	CbGeAlD
Gemcitabine—POLD1—cerebellum—brain cancer	0.000827	0.0156	CbGeAlD
Gemcitabine—SLC29A2—endocrine gland—brain cancer	0.000787	0.0149	CbGeAlD
Gemcitabine—POLA1—pituitary gland—brain cancer	0.000781	0.0148	CbGeAlD
Gemcitabine—RRM2—gonad—brain cancer	0.000765	0.0145	CbGeAlD
Gemcitabine—RRM1—telencephalon—brain cancer	0.000761	0.0144	CbGeAlD
Gemcitabine—CMPK1—endocrine gland—brain cancer	0.000749	0.0142	CbGeAlD
Gemcitabine—RRM2—pituitary gland—brain cancer	0.000746	0.0141	CbGeAlD
Gemcitabine—CMPK1—head—brain cancer	0.000739	0.014	CbGeAlD
Gemcitabine—POLE—endocrine gland—brain cancer	0.000702	0.0133	CbGeAlD
Gemcitabine—SLC29A2—cerebellum—brain cancer	0.000694	0.0131	CbGeAlD
Gemcitabine—POLE—head—brain cancer	0.000693	0.0131	CbGeAlD
Gemcitabine—TYMS—telencephalon—brain cancer	0.00069	0.0131	CbGeAlD
Gemcitabine—Zalcitabine—CYP2C9—brain cancer	0.000677	0.15	CrCbGaD
Gemcitabine—CMPK1—central nervous system—brain cancer	0.000675	0.0128	CbGeAlD
Gemcitabine—POLD1—brain—brain cancer	0.000672	0.0127	CbGeAlD
Gemcitabine—CMPK1—cerebellum—brain cancer	0.00066	0.0125	CbGeAlD
Gemcitabine—RRM1—gonad—brain cancer	0.000635	0.012	CbGeAlD
Gemcitabine—POLE—central nervous system—brain cancer	0.000632	0.012	CbGeAlD
Gemcitabine—RRM1—pituitary gland—brain cancer	0.00062	0.0117	CbGeAlD
Gemcitabine—SLC29A1—telencephalon—brain cancer	0.000619	0.0117	CbGeAlD
Gemcitabine—POLE—cerebellum—brain cancer	0.000618	0.0117	CbGeAlD
Gemcitabine—RRM1—medulla oblongata—brain cancer	0.000598	0.0113	CbGeAlD
Gemcitabine—DCK—telencephalon—brain cancer	0.000591	0.0112	CbGeAlD
Gemcitabine—RRM2—endocrine gland—brain cancer	0.000578	0.0109	CbGeAlD
Gemcitabine—TYMS—gonad—brain cancer	0.000576	0.0109	CbGeAlD
Gemcitabine—RRM2—head—brain cancer	0.000571	0.0108	CbGeAlD
Gemcitabine—SLC29A2—brain—brain cancer	0.000563	0.0107	CbGeAlD
Gemcitabine—ABCC10—telencephalon—brain cancer	0.000563	0.0107	CbGeAlD
Gemcitabine—RRM1—midbrain—brain cancer	0.000547	0.0103	CbGeAlD
Gemcitabine—CMPK1—brain—brain cancer	0.000536	0.0101	CbGeAlD
Gemcitabine—RRM1—spinal cord—brain cancer	0.000533	0.0101	CbGeAlD
Gemcitabine—POLA1—cerebellum—brain cancer	0.000533	0.0101	CbGeAlD
Gemcitabine—RRM2—central nervous system—brain cancer	0.000521	0.00985	CbGeAlD
Gemcitabine—SLC29A1—gonad—brain cancer	0.000517	0.00977	CbGeAlD
Gemcitabine—SLC29A1—pituitary gland—brain cancer	0.000504	0.00953	CbGeAlD
Gemcitabine—POLE—brain—brain cancer	0.000502	0.0095	CbGeAlD
Gemcitabine—TYMS—midbrain—brain cancer	0.000496	0.00937	CbGeAlD
Gemcitabine—DCK—gonad—brain cancer	0.000493	0.00933	CbGeAlD
Gemcitabine—DCK—pituitary gland—brain cancer	0.000481	0.0091	CbGeAlD
Gemcitabine—RRM1—endocrine gland—brain cancer	0.00048	0.00908	CbGeAlD
Gemcitabine—RRM1—head—brain cancer	0.000474	0.00896	CbGeAlD
Gemcitabine—ABCC10—gonad—brain cancer	0.00047	0.00889	CbGeAlD
Gemcitabine—DCK—medulla oblongata—brain cancer	0.000465	0.00879	CbGeAlD
Gemcitabine—ABCC10—pituitary gland—brain cancer	0.000459	0.00867	CbGeAlD
Gemcitabine—ABCC10—medulla oblongata—brain cancer	0.000443	0.00837	CbGeAlD
Gemcitabine—TYMS—endocrine gland—brain cancer	0.000435	0.00823	CbGeAlD
Gemcitabine—POLA1—brain—brain cancer	0.000433	0.00818	CbGeAlD
Gemcitabine—RRM1—central nervous system—brain cancer	0.000433	0.00818	CbGeAlD
Gemcitabine—TYMS—head—brain cancer	0.00043	0.00813	CbGeAlD
Gemcitabine—DCK—midbrain—brain cancer	0.000425	0.00803	CbGeAlD
Gemcitabine—RRM1—cerebellum—brain cancer	0.000423	0.008	CbGeAlD
Gemcitabine—DCK—spinal cord—brain cancer	0.000414	0.00783	CbGeAlD
Gemcitabine—RRM2—brain—brain cancer	0.000413	0.00782	CbGeAlD
Gemcitabine—ABCC10—midbrain—brain cancer	0.000405	0.00765	CbGeAlD
Gemcitabine—ABCC10—spinal cord—brain cancer	0.000395	0.00746	CbGeAlD
Gemcitabine—TYMS—central nervous system—brain cancer	0.000392	0.00742	CbGeAlD
Gemcitabine—SLC29A1—endocrine gland—brain cancer	0.00039	0.00738	CbGeAlD
Gemcitabine—SLC29A1—head—brain cancer	0.000385	0.00729	CbGeAlD
Gemcitabine—TYMS—cerebellum—brain cancer	0.000383	0.00725	CbGeAlD
Gemcitabine—DCK—endocrine gland—brain cancer	0.000373	0.00705	CbGeAlD
Gemcitabine—DCK—head—brain cancer	0.000368	0.00696	CbGeAlD
Gemcitabine—ABCC10—endocrine gland—brain cancer	0.000355	0.00672	CbGeAlD
Gemcitabine—SLC29A1—central nervous system—brain cancer	0.000352	0.00665	CbGeAlD
Gemcitabine—SLC29A1—cerebellum—brain cancer	0.000344	0.0065	CbGeAlD
Gemcitabine—RRM1—brain—brain cancer	0.000344	0.0065	CbGeAlD
Gemcitabine—DCK—central nervous system—brain cancer	0.000336	0.00636	CbGeAlD
Gemcitabine—ABCB1—blood vessel—brain cancer	0.000335	0.00634	CbGeAlD
Gemcitabine—DCK—cerebellum—brain cancer	0.000328	0.00621	CbGeAlD
Gemcitabine—ABCC10—cerebellum—brain cancer	0.000313	0.00592	CbGeAlD
Gemcitabine—TYMS—brain—brain cancer	0.000311	0.00589	CbGeAlD
Gemcitabine—Neutropenia—Hydroxyurea—brain cancer	0.000299	0.00203	CcSEcCtD
Gemcitabine—Chills—Procarbazine—brain cancer	0.000296	0.00202	CcSEcCtD
Gemcitabine—Arrhythmia—Procarbazine—brain cancer	0.000295	0.00201	CcSEcCtD
Gemcitabine—Body temperature increased—Lomustine—brain cancer	0.000292	0.00199	CcSEcCtD
Gemcitabine—Alopecia—Procarbazine—brain cancer	0.000292	0.00199	CcSEcCtD
Gemcitabine—Face oedema—Carmustine—brain cancer	0.000288	0.00196	CcSEcCtD
Gemcitabine—SLC29A1—brain—brain cancer	0.000279	0.00528	CbGeAlD
Gemcitabine—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000279	0.0019	CcSEcCtD
Gemcitabine—Face oedema—Temozolomide—brain cancer	0.000279	0.0019	CcSEcCtD
Gemcitabine—Stomatitis—Hydroxyurea—brain cancer	0.000278	0.00189	CcSEcCtD
Gemcitabine—Sepsis—Etoposide—brain cancer	0.000276	0.00188	CcSEcCtD
Gemcitabine—Liver function test abnormal—Carmustine—brain cancer	0.000276	0.00188	CcSEcCtD
Gemcitabine—Hypokalaemia—Carmustine—brain cancer	0.000272	0.00185	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000269	0.00183	CcSEcCtD
Gemcitabine—DCK—brain—brain cancer	0.000267	0.00505	CbGeAlD
Gemcitabine—Anaemia—Procarbazine—brain cancer	0.000266	0.00181	CcSEcCtD
Gemcitabine—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.000266	0.00181	CcSEcCtD
Gemcitabine—Hypokalaemia—Temozolomide—brain cancer	0.000263	0.00179	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.00026	0.00177	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.00026	0.00177	CcSEcCtD
Gemcitabine—Leukopenia—Procarbazine—brain cancer	0.000257	0.00175	CcSEcCtD
Gemcitabine—Haemoglobin—Hydroxyurea—brain cancer	0.000257	0.00175	CcSEcCtD
Gemcitabine—Haemorrhage—Hydroxyurea—brain cancer	0.000256	0.00174	CcSEcCtD
Gemcitabine—Cardiac failure congestive—Etoposide—brain cancer	0.000255	0.00173	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000255	0.00173	CcSEcCtD
Gemcitabine—ABCC10—brain—brain cancer	0.000254	0.00481	CbGeAlD
Gemcitabine—Cough—Procarbazine—brain cancer	0.000251	0.00171	CcSEcCtD
Gemcitabine—Hypertension—Procarbazine—brain cancer	0.000248	0.00169	CcSEcCtD
Gemcitabine—Pancytopenia—Carmustine—brain cancer	0.000245	0.00167	CcSEcCtD
Gemcitabine—Arthralgia—Procarbazine—brain cancer	0.000245	0.00167	CcSEcCtD
Gemcitabine—Myalgia—Procarbazine—brain cancer	0.000245	0.00167	CcSEcCtD
Gemcitabine—Neutropenia—Carmustine—brain cancer	0.000242	0.00164	CcSEcCtD
Gemcitabine—Anaphylactoid reaction—Etoposide—brain cancer	0.000239	0.00163	CcSEcCtD
Gemcitabine—Pancytopenia—Temozolomide—brain cancer	0.000237	0.00161	CcSEcCtD
Gemcitabine—Cardiac failure—Etoposide—brain cancer	0.000237	0.00161	CcSEcCtD
Gemcitabine—Vomiting—Lomustine—brain cancer	0.000235	0.0016	CcSEcCtD
Gemcitabine—Oedema—Procarbazine—brain cancer	0.000235	0.0016	CcSEcCtD
Gemcitabine—Neutropenia—Temozolomide—brain cancer	0.000233	0.00159	CcSEcCtD
Gemcitabine—Infection—Procarbazine—brain cancer	0.000233	0.00159	CcSEcCtD
Gemcitabine—Hyperglycaemia—Carmustine—brain cancer	0.000233	0.00159	CcSEcCtD
Gemcitabine—Angiopathy—Hydroxyurea—brain cancer	0.000232	0.00158	CcSEcCtD
Gemcitabine—Pneumonia—Carmustine—brain cancer	0.000232	0.00158	CcSEcCtD
Gemcitabine—Thrombocytopenia—Procarbazine—brain cancer	0.00023	0.00156	CcSEcCtD
Gemcitabine—Chills—Hydroxyurea—brain cancer	0.000229	0.00156	CcSEcCtD
Gemcitabine—Hyperhidrosis—Procarbazine—brain cancer	0.000227	0.00154	CcSEcCtD
Gemcitabine—Renal failure—Carmustine—brain cancer	0.000226	0.00154	CcSEcCtD
Gemcitabine—Alopecia—Hydroxyurea—brain cancer	0.000226	0.00154	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Carmustine—brain cancer	0.000226	0.00154	CcSEcCtD
Gemcitabine—Hyperglycaemia—Temozolomide—brain cancer	0.000225	0.00153	CcSEcCtD
Gemcitabine—Stomatitis—Carmustine—brain cancer	0.000224	0.00153	CcSEcCtD
Gemcitabine—Pneumonia—Temozolomide—brain cancer	0.000224	0.00152	CcSEcCtD
Gemcitabine—Anorexia—Procarbazine—brain cancer	0.000224	0.00152	CcSEcCtD
Gemcitabine—Erythema—Hydroxyurea—brain cancer	0.000223	0.00152	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000221	0.0015	CcSEcCtD
Gemcitabine—Nausea—Lomustine—brain cancer	0.00022	0.00149	CcSEcCtD
Gemcitabine—Hypotension—Procarbazine—brain cancer	0.000219	0.00149	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Temozolomide—brain cancer	0.000218	0.00148	CcSEcCtD
Gemcitabine—Stomatitis—Temozolomide—brain cancer	0.000217	0.00148	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000214	0.00146	CcSEcCtD
Gemcitabine—Insomnia—Procarbazine—brain cancer	0.000212	0.00145	CcSEcCtD
Gemcitabine—Paraesthesia—Procarbazine—brain cancer	0.000211	0.00143	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Temozolomide—brain cancer	0.00021	0.00143	CcSEcCtD
Gemcitabine—Somnolence—Procarbazine—brain cancer	0.000209	0.00142	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000208	0.00142	CcSEcCtD
Gemcitabine—Haemoglobin—Carmustine—brain cancer	0.000208	0.00141	CcSEcCtD
Gemcitabine—Haemorrhage—Carmustine—brain cancer	0.000207	0.00141	CcSEcCtD
Gemcitabine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000207	0.00141	CcSEcCtD
Gemcitabine—Anaemia—Hydroxyurea—brain cancer	0.000206	0.0014	CcSEcCtD
Gemcitabine—Decreased appetite—Procarbazine—brain cancer	0.000204	0.00139	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Etoposide—brain cancer	0.000204	0.00139	CcSEcCtD
Gemcitabine—Oedema peripheral—Carmustine—brain cancer	0.000204	0.00139	CcSEcCtD
Gemcitabine—Connective tissue disorder—Carmustine—brain cancer	0.000203	0.00138	CcSEcCtD
Gemcitabine—Fatigue—Procarbazine—brain cancer	0.000202	0.00138	CcSEcCtD
Gemcitabine—Haemoglobin—Temozolomide—brain cancer	0.000201	0.00137	CcSEcCtD
Gemcitabine—Malaise—Hydroxyurea—brain cancer	0.000201	0.00137	CcSEcCtD
Gemcitabine—Pain—Procarbazine—brain cancer	0.000201	0.00137	CcSEcCtD
Gemcitabine—Constipation—Procarbazine—brain cancer	0.000201	0.00137	CcSEcCtD
Gemcitabine—Haemorrhage—Temozolomide—brain cancer	0.0002	0.00136	CcSEcCtD
Gemcitabine—Leukopenia—Hydroxyurea—brain cancer	0.000199	0.00136	CcSEcCtD
Gemcitabine—Pharyngitis—Temozolomide—brain cancer	0.000198	0.00135	CcSEcCtD
Gemcitabine—Urinary tract disorder—Temozolomide—brain cancer	0.000197	0.00134	CcSEcCtD
Gemcitabine—Oedema peripheral—Temozolomide—brain cancer	0.000197	0.00134	CcSEcCtD
Gemcitabine—Bronchospasm—Etoposide—brain cancer	0.000196	0.00134	CcSEcCtD
Gemcitabine—Connective tissue disorder—Temozolomide—brain cancer	0.000196	0.00134	CcSEcCtD
Gemcitabine—Urethral disorder—Temozolomide—brain cancer	0.000196	0.00133	CcSEcCtD
Gemcitabine—Feeling abnormal—Procarbazine—brain cancer	0.000193	0.00132	CcSEcCtD
Gemcitabine—Pancytopenia—Etoposide—brain cancer	0.00019	0.00129	CcSEcCtD
Gemcitabine—Erythema multiforme—Temozolomide—brain cancer	0.000189	0.00129	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000188	0.00128	CcSEcCtD
Gemcitabine—Discomfort—Hydroxyurea—brain cancer	0.000187	0.00127	CcSEcCtD
Gemcitabine—Neutropenia—Etoposide—brain cancer	0.000187	0.00127	CcSEcCtD
Gemcitabine—Body temperature increased—Procarbazine—brain cancer	0.000186	0.00126	CcSEcCtD
Gemcitabine—Cardiac disorder—Temozolomide—brain cancer	0.000185	0.00126	CcSEcCtD
Gemcitabine—Arrhythmia—Carmustine—brain cancer	0.000185	0.00126	CcSEcCtD
Gemcitabine—Alopecia—Carmustine—brain cancer	0.000183	0.00124	CcSEcCtD
Gemcitabine—Oedema—Hydroxyurea—brain cancer	0.000182	0.00124	CcSEcCtD
Gemcitabine—Angiopathy—Temozolomide—brain cancer	0.000181	0.00123	CcSEcCtD
Gemcitabine—Infection—Hydroxyurea—brain cancer	0.00018	0.00123	CcSEcCtD
Gemcitabine—Immune system disorder—Temozolomide—brain cancer	0.00018	0.00123	CcSEcCtD
Gemcitabine—Mediastinal disorder—Temozolomide—brain cancer	0.00018	0.00123	CcSEcCtD
Gemcitabine—Erythema—Carmustine—brain cancer	0.00018	0.00122	CcSEcCtD
Gemcitabine—Chills—Temozolomide—brain cancer	0.000179	0.00122	CcSEcCtD
Gemcitabine—Pneumonia—Etoposide—brain cancer	0.000179	0.00122	CcSEcCtD
Gemcitabine—Nervous system disorder—Hydroxyurea—brain cancer	0.000178	0.00121	CcSEcCtD
Gemcitabine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000178	0.00121	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000177	0.0012	CcSEcCtD
Gemcitabine—Alopecia—Temozolomide—brain cancer	0.000177	0.0012	CcSEcCtD
Gemcitabine—Skin disorder—Hydroxyurea—brain cancer	0.000176	0.0012	CcSEcCtD
Gemcitabine—Acute coronary syndrome—Etoposide—brain cancer	0.000176	0.00119	CcSEcCtD
Gemcitabine—Renal failure—Etoposide—brain cancer	0.000175	0.00119	CcSEcCtD
Gemcitabine—Myocardial infarction—Etoposide—brain cancer	0.000175	0.00119	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Etoposide—brain cancer	0.000175	0.00119	CcSEcCtD
Gemcitabine—Back pain—Carmustine—brain cancer	0.000174	0.00118	CcSEcCtD
Gemcitabine—Erythema—Temozolomide—brain cancer	0.000174	0.00118	CcSEcCtD
Gemcitabine—Stomatitis—Etoposide—brain cancer	0.000174	0.00118	CcSEcCtD
Gemcitabine—Anorexia—Hydroxyurea—brain cancer	0.000173	0.00118	CcSEcCtD
Gemcitabine—Asthenia—Procarbazine—brain cancer	0.000168	0.00115	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Etoposide—brain cancer	0.000168	0.00115	CcSEcCtD
Gemcitabine—Back pain—Temozolomide—brain cancer	0.000168	0.00115	CcSEcCtD
Gemcitabine—Anaemia—Carmustine—brain cancer	0.000166	0.00113	CcSEcCtD
Gemcitabine—Agranulocytosis—Etoposide—brain cancer	0.000166	0.00113	CcSEcCtD
Gemcitabine—Pruritus—Procarbazine—brain cancer	0.000166	0.00113	CcSEcCtD
Gemcitabine—ABCB1—telencephalon—brain cancer	0.000163	0.00308	CbGeAlD
Gemcitabine—Dyspnoea—Hydroxyurea—brain cancer	0.000162	0.0011	CcSEcCtD
Gemcitabine—Somnolence—Hydroxyurea—brain cancer	0.000162	0.0011	CcSEcCtD
Gemcitabine—Ill-defined disorder—Temozolomide—brain cancer	0.000161	0.0011	CcSEcCtD
Gemcitabine—Leukopenia—Carmustine—brain cancer	0.000161	0.0011	CcSEcCtD
Gemcitabine—Anaemia—Temozolomide—brain cancer	0.000161	0.00109	CcSEcCtD
Gemcitabine—Diarrhoea—Procarbazine—brain cancer	0.000161	0.00109	CcSEcCtD
Gemcitabine—Decreased appetite—Hydroxyurea—brain cancer	0.000158	0.00108	CcSEcCtD
Gemcitabine—Urinary tract disorder—Etoposide—brain cancer	0.000158	0.00107	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000157	0.00107	CcSEcCtD
Gemcitabine—Malaise—Temozolomide—brain cancer	0.000157	0.00107	CcSEcCtD
Gemcitabine—Urethral disorder—Etoposide—brain cancer	0.000157	0.00107	CcSEcCtD
Gemcitabine—Fatigue—Hydroxyurea—brain cancer	0.000157	0.00107	CcSEcCtD
Gemcitabine—Leukopenia—Temozolomide—brain cancer	0.000156	0.00106	CcSEcCtD
Gemcitabine—Hypertension—Carmustine—brain cancer	0.000155	0.00106	CcSEcCtD
Gemcitabine—Pain—Hydroxyurea—brain cancer	0.000155	0.00106	CcSEcCtD
Gemcitabine—Constipation—Hydroxyurea—brain cancer	0.000155	0.00106	CcSEcCtD
Gemcitabine—Chest pain—Carmustine—brain cancer	0.000153	0.00104	CcSEcCtD
Gemcitabine—Myalgia—Carmustine—brain cancer	0.000153	0.00104	CcSEcCtD
Gemcitabine—Cough—Temozolomide—brain cancer	0.000152	0.00103	CcSEcCtD
Gemcitabine—Erythema multiforme—Etoposide—brain cancer	0.000151	0.00103	CcSEcCtD
Gemcitabine—Hypertension—Temozolomide—brain cancer	0.00015	0.00102	CcSEcCtD
Gemcitabine—Feeling abnormal—Hydroxyurea—brain cancer	0.00015	0.00102	CcSEcCtD
Gemcitabine—Vomiting—Procarbazine—brain cancer	0.000149	0.00102	CcSEcCtD
Gemcitabine—Cardiac disorder—Etoposide—brain cancer	0.000148	0.00101	CcSEcCtD
Gemcitabine—Myalgia—Temozolomide—brain cancer	0.000148	0.00101	CcSEcCtD
Gemcitabine—Arthralgia—Temozolomide—brain cancer	0.000148	0.00101	CcSEcCtD
Gemcitabine—Rash—Procarbazine—brain cancer	0.000148	0.00101	CcSEcCtD
Gemcitabine—Dermatitis—Procarbazine—brain cancer	0.000148	0.00101	CcSEcCtD
Gemcitabine—Headache—Procarbazine—brain cancer	0.000147	0.001	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000147	0.001	CcSEcCtD
Gemcitabine—Oedema—Carmustine—brain cancer	0.000147	0.001	CcSEcCtD
Gemcitabine—Discomfort—Temozolomide—brain cancer	0.000146	0.000996	CcSEcCtD
Gemcitabine—Infection—Carmustine—brain cancer	0.000146	0.000993	CcSEcCtD
Gemcitabine—Angiopathy—Etoposide—brain cancer	0.000145	0.000987	CcSEcCtD
Gemcitabine—Immune system disorder—Etoposide—brain cancer	0.000144	0.000983	CcSEcCtD
Gemcitabine—Mediastinal disorder—Etoposide—brain cancer	0.000144	0.000981	CcSEcCtD
Gemcitabine—Thrombocytopenia—Carmustine—brain cancer	0.000144	0.000979	CcSEcCtD
Gemcitabine—Body temperature increased—Hydroxyurea—brain cancer	0.000144	0.000978	CcSEcCtD
Gemcitabine—Chills—Etoposide—brain cancer	0.000143	0.000976	CcSEcCtD
Gemcitabine—Oedema—Temozolomide—brain cancer	0.000142	0.000966	CcSEcCtD
Gemcitabine—Anaphylactic shock—Temozolomide—brain cancer	0.000142	0.000966	CcSEcCtD
Gemcitabine—Alopecia—Etoposide—brain cancer	0.000141	0.000962	CcSEcCtD
Gemcitabine—Infection—Temozolomide—brain cancer	0.000141	0.00096	CcSEcCtD
Gemcitabine—Anorexia—Carmustine—brain cancer	0.00014	0.000953	CcSEcCtD
Gemcitabine—Nausea—Procarbazine—brain cancer	0.000139	0.000949	CcSEcCtD
Gemcitabine—Nervous system disorder—Temozolomide—brain cancer	0.000139	0.000947	CcSEcCtD
Gemcitabine—Thrombocytopenia—Temozolomide—brain cancer	0.000139	0.000946	CcSEcCtD
Gemcitabine—Skin disorder—Temozolomide—brain cancer	0.000138	0.000938	CcSEcCtD
Gemcitabine—Hypotension—Carmustine—brain cancer	0.000137	0.000934	CcSEcCtD
Gemcitabine—Hyperhidrosis—Temozolomide—brain cancer	0.000137	0.000934	CcSEcCtD
Gemcitabine—ABCB1—gonad—brain cancer	0.000136	0.00257	CbGeAlD
Gemcitabine—Anorexia—Temozolomide—brain cancer	0.000135	0.000921	CcSEcCtD
Gemcitabine—Back pain—Etoposide—brain cancer	0.000135	0.000916	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000134	0.000911	CcSEcCtD
Gemcitabine—Insomnia—Carmustine—brain cancer	0.000133	0.000904	CcSEcCtD
Gemcitabine—ABCB1—pituitary gland—brain cancer	0.000132	0.0025	CbGeAlD
Gemcitabine—Paraesthesia—Carmustine—brain cancer	0.000132	0.000898	CcSEcCtD
Gemcitabine—Dyspnoea—Carmustine—brain cancer	0.000131	0.000891	CcSEcCtD
Gemcitabine—Somnolence—Carmustine—brain cancer	0.000131	0.000889	CcSEcCtD
Gemcitabine—Asthenia—Hydroxyurea—brain cancer	0.00013	0.000887	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000129	0.00088	CcSEcCtD
Gemcitabine—Ill-defined disorder—Etoposide—brain cancer	0.000129	0.000879	CcSEcCtD
Gemcitabine—Anaemia—Etoposide—brain cancer	0.000129	0.000876	CcSEcCtD
Gemcitabine—Insomnia—Temozolomide—brain cancer	0.000128	0.000874	CcSEcCtD
Gemcitabine—ABCB1—medulla oblongata—brain cancer	0.000128	0.00242	CbGeAlD
Gemcitabine—Decreased appetite—Carmustine—brain cancer	0.000128	0.000869	CcSEcCtD
Gemcitabine—Paraesthesia—Temozolomide—brain cancer	0.000127	0.000868	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Carmustine—brain cancer	0.000127	0.000863	CcSEcCtD
Gemcitabine—Dyspnoea—Temozolomide—brain cancer	0.000127	0.000861	CcSEcCtD
Gemcitabine—Somnolence—Temozolomide—brain cancer	0.000126	0.000859	CcSEcCtD
Gemcitabine—Pain—Carmustine—brain cancer	0.000126	0.000855	CcSEcCtD
Gemcitabine—Constipation—Carmustine—brain cancer	0.000126	0.000855	CcSEcCtD
Gemcitabine—Malaise—Etoposide—brain cancer	0.000125	0.000854	CcSEcCtD
Gemcitabine—Leukopenia—Etoposide—brain cancer	0.000125	0.000848	CcSEcCtD
Gemcitabine—Diarrhoea—Hydroxyurea—brain cancer	0.000124	0.000846	CcSEcCtD
Gemcitabine—Decreased appetite—Temozolomide—brain cancer	0.000123	0.00084	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000123	0.000834	CcSEcCtD
Gemcitabine—Fatigue—Temozolomide—brain cancer	0.000122	0.000833	CcSEcCtD
Gemcitabine—Cough—Etoposide—brain cancer	0.000121	0.000827	CcSEcCtD
Gemcitabine—Pain—Temozolomide—brain cancer	0.000121	0.000826	CcSEcCtD
Gemcitabine—Constipation—Temozolomide—brain cancer	0.000121	0.000826	CcSEcCtD
Gemcitabine—Feeling abnormal—Carmustine—brain cancer	0.000121	0.000824	CcSEcCtD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000121	0.00129	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000121	0.00128	CbGpPWpGaD
Gemcitabine—Hypertension—Etoposide—brain cancer	0.00012	0.000818	CcSEcCtD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.00012	0.00128	CbGpPWpGaD
Gemcitabine—Chest pain—Etoposide—brain cancer	0.000118	0.000806	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000118	0.00126	CbGpPWpGaD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000118	0.000801	CcSEcCtD
Gemcitabine—POLE—G1 to S cell cycle control—MYC—brain cancer	0.000117	0.00125	CbGpPWpGaD
Gemcitabine—TYMS—Fluoropyrimidine Activity—TP53—brain cancer	0.000117	0.00125	CbGpPWpGaD
Gemcitabine—Discomfort—Etoposide—brain cancer	0.000117	0.000797	CcSEcCtD
Gemcitabine—Feeling abnormal—Temozolomide—brain cancer	0.000117	0.000796	CcSEcCtD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.000117	0.00124	CbGpPWpGaD
Gemcitabine—ABCB1—midbrain—brain cancer	0.000117	0.00221	CbGeAlD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CCNE1—brain cancer	0.000117	0.00124	CbGpPWpGaD
Gemcitabine—POLA1—E2F transcription factor network—CDKN2A—brain cancer	0.000116	0.00124	CbGpPWpGaD
Gemcitabine—POLA1—S Phase—PCNA—brain cancer	0.000116	0.00124	CbGpPWpGaD
Gemcitabine—Body temperature increased—Carmustine—brain cancer	0.000116	0.00079	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000116	0.00123	CbGpPWpGaD
Gemcitabine—Vomiting—Hydroxyurea—brain cancer	0.000116	0.000786	CcSEcCtD
Gemcitabine—RRM2—E2F transcription factor network—MYC—brain cancer	0.000115	0.00123	CbGpPWpGaD
Gemcitabine—Rash—Hydroxyurea—brain cancer	0.000115	0.00078	CcSEcCtD
Gemcitabine—Dermatitis—Hydroxyurea—brain cancer	0.000114	0.000779	CcSEcCtD
Gemcitabine—ABCB1—spinal cord—brain cancer	0.000114	0.00216	CbGeAlD
Gemcitabine—Headache—Hydroxyurea—brain cancer	0.000114	0.000775	CcSEcCtD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000114	0.00121	CbGpPWpGaD
Gemcitabine—Anaphylactic shock—Etoposide—brain cancer	0.000114	0.000773	CcSEcCtD
Gemcitabine—Infection—Etoposide—brain cancer	0.000113	0.000768	CcSEcCtD
Gemcitabine—Body temperature increased—Temozolomide—brain cancer	0.000112	0.000764	CcSEcCtD
Gemcitabine—TYMS—E2F transcription factor network—CDKN2A—brain cancer	0.000112	0.00119	CbGpPWpGaD
Gemcitabine—Thrombocytopenia—Etoposide—brain cancer	0.000111	0.000757	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000111	0.00118	CbGpPWpGaD
Gemcitabine—Skin disorder—Etoposide—brain cancer	0.00011	0.000751	CcSEcCtD
Gemcitabine—Hyperhidrosis—Etoposide—brain cancer	0.00011	0.000747	CcSEcCtD
Gemcitabine—CDA—Metabolism—CYP2C9—brain cancer	0.000109	0.00116	CbGpPWpGaD
Gemcitabine—Anorexia—Etoposide—brain cancer	0.000108	0.000737	CcSEcCtD
Gemcitabine—Nausea—Hydroxyurea—brain cancer	0.000108	0.000735	CcSEcCtD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—PCNA—brain cancer	0.000108	0.00115	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000107	0.00114	CbGpPWpGaD
Gemcitabine—Hypotension—Etoposide—brain cancer	0.000106	0.000722	CcSEcCtD
Gemcitabine—Asthenia—Carmustine—brain cancer	0.000105	0.000717	CcSEcCtD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—CDKN2A—brain cancer	0.000104	0.00111	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—PCNA—brain cancer	0.000103	0.0011	CbGpPWpGaD
Gemcitabine—ABCB1—endocrine gland—brain cancer	0.000103	0.00194	CbGeAlD
Gemcitabine—CMPK1—Metabolism—ENO2—brain cancer	0.000102	0.00109	CbGpPWpGaD
Gemcitabine—Paraesthesia—Etoposide—brain cancer	0.000102	0.000694	CcSEcCtD
Gemcitabine—Asthenia—Temozolomide—brain cancer	0.000102	0.000693	CcSEcCtD
Gemcitabine—ABCB1—head—brain cancer	0.000101	0.00192	CbGeAlD
Gemcitabine—Dyspnoea—Etoposide—brain cancer	0.000101	0.000689	CcSEcCtD
Gemcitabine—Somnolence—Etoposide—brain cancer	0.000101	0.000687	CcSEcCtD
Gemcitabine—Diarrhoea—Carmustine—brain cancer	0.0001	0.000684	CcSEcCtD
Gemcitabine—Pruritus—Temozolomide—brain cancer	0.0001	0.000684	CcSEcCtD
Gemcitabine—POLA1—S Phase—CDK4—brain cancer	0.0001	0.00107	CbGpPWpGaD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.0001	0.00107	CbGpPWpGaD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.0001	0.00106	CbGpPWpGaD
Gemcitabine—POLE—Mitotic G1-G1/S phases—CDKN2A—brain cancer	0.0001	0.00106	CbGpPWpGaD
Gemcitabine—Decreased appetite—Etoposide—brain cancer	9.87e-05	0.000672	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Etoposide—brain cancer	9.8e-05	0.000667	CcSEcCtD
Gemcitabine—Fatigue—Etoposide—brain cancer	9.79e-05	0.000667	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle, Mitotic—SKP2—brain cancer	9.72e-05	0.00103	CbGpPWpGaD
Gemcitabine—Constipation—Etoposide—brain cancer	9.71e-05	0.000661	CcSEcCtD
Gemcitabine—Pain—Etoposide—brain cancer	9.71e-05	0.000661	CcSEcCtD
Gemcitabine—Diarrhoea—Temozolomide—brain cancer	9.71e-05	0.000661	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle, Mitotic—SKP2—brain cancer	9.66e-05	0.00103	CbGpPWpGaD
Gemcitabine—POLE—G1 to S cell cycle control—TP53—brain cancer	9.63e-05	0.00102	CbGpPWpGaD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—MYC—brain cancer	9.63e-05	0.00102	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	9.52e-05	0.00101	CbGpPWpGaD
Gemcitabine—POLD1—S Phase—CCND1—brain cancer	9.42e-05	0.001	CbGpPWpGaD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—MYC—brain cancer	9.37e-05	0.000997	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Etoposide—brain cancer	9.36e-05	0.000637	CcSEcCtD
Gemcitabine—Vomiting—Carmustine—brain cancer	9.34e-05	0.000636	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	9.34e-05	0.000993	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—SKP2—brain cancer	9.33e-05	0.000993	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CDK4—brain cancer	9.32e-05	0.000991	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—BSG—brain cancer	9.29e-05	0.000988	CbGpPWpGaD
Gemcitabine—Rash—Carmustine—brain cancer	9.26e-05	0.00063	CcSEcCtD
Gemcitabine—Dermatitis—Carmustine—brain cancer	9.25e-05	0.00063	CcSEcCtD
Gemcitabine—ABCB1—central nervous system—brain cancer	9.25e-05	0.00175	CbGeAlD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	9.22e-05	0.000981	CbGpPWpGaD
Gemcitabine—Headache—Carmustine—brain cancer	9.2e-05	0.000626	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	9.16e-05	0.000975	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	9.12e-05	0.00097	CbGpPWpGaD
Gemcitabine—POLE—S Phase—CCND1—brain cancer	9.1e-05	0.000968	CbGpPWpGaD
Gemcitabine—ABCB1—cerebellum—brain cancer	9.04e-05	0.00171	CbGeAlD
Gemcitabine—Vomiting—Temozolomide—brain cancer	9.02e-05	0.000614	CcSEcCtD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—TRPC6—brain cancer	9.01e-05	0.000958	CbGpPWpGaD
Gemcitabine—Body temperature increased—Etoposide—brain cancer	8.98e-05	0.000611	CcSEcCtD
Gemcitabine—Rash—Temozolomide—brain cancer	8.95e-05	0.000609	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	8.94e-05	0.000952	CbGpPWpGaD
Gemcitabine—Dermatitis—Temozolomide—brain cancer	8.94e-05	0.000609	CcSEcCtD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CDK4—brain cancer	8.93e-05	0.00095	CbGpPWpGaD
Gemcitabine—Headache—Temozolomide—brain cancer	8.89e-05	0.000605	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	8.83e-05	0.00094	CbGpPWpGaD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—CCND1—brain cancer	8.8e-05	0.000936	CbGpPWpGaD
Gemcitabine—Nausea—Carmustine—brain cancer	8.72e-05	0.000594	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle—SKP2—brain cancer	8.69e-05	0.000925	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDK6—brain cancer	8.66e-05	0.000922	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—SKP2—brain cancer	8.64e-05	0.000919	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDK6—brain cancer	8.61e-05	0.000916	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—SIRT1—brain cancer	8.59e-05	0.000914	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	8.57e-05	0.000912	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	8.55e-05	0.00091	CbGpPWpGaD
Gemcitabine—POLE—Mitotic G1-G1/S phases—CCND1—brain cancer	8.45e-05	0.000899	CbGpPWpGaD
Gemcitabine—Nausea—Temozolomide—brain cancer	8.43e-05	0.000574	CcSEcCtD
Gemcitabine—RRM2—G1/S Transition—MYC—brain cancer	8.37e-05	0.000891	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—SKP2—brain cancer	8.34e-05	0.000888	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDK6—brain cancer	8.32e-05	0.000885	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CYP2C9—brain cancer	8.28e-05	0.00088	CbGpPWpGaD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—brain cancer	8.24e-05	0.000876	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	8.21e-05	0.000874	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	8.19e-05	0.000872	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	8.17e-05	0.000869	CbGpPWpGaD
Gemcitabine—Asthenia—Etoposide—brain cancer	8.15e-05	0.000555	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	8.09e-05	0.000861	CbGpPWpGaD
Gemcitabine—POLE—G1/S Transition—MYC—brain cancer	8.04e-05	0.000855	CbGpPWpGaD
Gemcitabine—Pruritus—Etoposide—brain cancer	8.04e-05	0.000547	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	8.02e-05	0.000853	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—IDH1—brain cancer	7.98e-05	0.000849	CbGpPWpGaD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—TP53—brain cancer	7.91e-05	0.000841	CbGpPWpGaD
Gemcitabine—POLA1—E2F transcription factor network—MYC—brain cancer	7.89e-05	0.00084	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	7.83e-05	0.000833	CbGpPWpGaD
Gemcitabine—Diarrhoea—Etoposide—brain cancer	7.77e-05	0.000529	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle—CDK6—brain cancer	7.75e-05	0.000824	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDK6—brain cancer	7.7e-05	0.000819	CbGpPWpGaD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—brain cancer	7.7e-05	0.000819	CbGpPWpGaD
Gemcitabine—TYMS—E2F transcription factor network—MYC—brain cancer	7.56e-05	0.000805	CbGpPWpGaD
Gemcitabine—POLD1—S Phase—MYC—brain cancer	7.56e-05	0.000804	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	7.52e-05	0.0008	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDK6—brain cancer	7.44e-05	0.000791	CbGpPWpGaD
Gemcitabine—ABCB1—brain—brain cancer	7.34e-05	0.00139	CbGeAlD
Gemcitabine—POLE—S Phase—MYC—brain cancer	7.3e-05	0.000776	CbGpPWpGaD
Gemcitabine—Vomiting—Etoposide—brain cancer	7.22e-05	0.000492	CcSEcCtD
Gemcitabine—Rash—Etoposide—brain cancer	7.16e-05	0.000487	CcSEcCtD
Gemcitabine—Dermatitis—Etoposide—brain cancer	7.15e-05	0.000487	CcSEcCtD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—brain cancer	7.12e-05	0.000758	CbGpPWpGaD
Gemcitabine—Headache—Etoposide—brain cancer	7.11e-05	0.000484	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	7.06e-05	0.000751	CbGpPWpGaD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—MYC—brain cancer	7.06e-05	0.000751	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	7.06e-05	0.000751	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—BSG—brain cancer	7.04e-05	0.000749	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—brain cancer	6.86e-05	0.00073	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CDKN2A—brain cancer	6.82e-05	0.000726	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYP2C9—brain cancer	6.82e-05	0.000725	CbGpPWpGaD
Gemcitabine—POLE—Mitotic G1-G1/S phases—MYC—brain cancer	6.77e-05	0.000721	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP2C9—brain cancer	6.77e-05	0.000721	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	6.76e-05	0.00072	CbGpPWpGaD
Gemcitabine—Nausea—Etoposide—brain cancer	6.75e-05	0.000459	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle, Mitotic—SKP2—brain cancer	6.65e-05	0.000707	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	6.65e-05	0.000707	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—MYC—brain cancer	6.57e-05	0.000699	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CCNE1—brain cancer	6.53e-05	0.000694	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—CDK4—brain cancer	6.49e-05	0.000691	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	6.49e-05	0.000691	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CCNE1—brain cancer	6.49e-05	0.00069	CbGpPWpGaD
Gemcitabine—POLA1—S Phase—CCND1—brain cancer	6.48e-05	0.00069	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—SKP2—brain cancer	6.37e-05	0.000678	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP2C9—brain cancer	6.37e-05	0.000678	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—APC—brain cancer	6.37e-05	0.000677	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	6.35e-05	0.000676	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ENO2—brain cancer	6.31e-05	0.000672	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CCNE1—brain cancer	6.26e-05	0.000666	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—IDH1—brain cancer	6.05e-05	0.000644	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—BRCA2—brain cancer	6.02e-05	0.000641	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CCND1—brain cancer	6.02e-05	0.00064	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—BRCA2—brain cancer	5.99e-05	0.000637	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—SKP2—brain cancer	5.95e-05	0.000632	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDK6—brain cancer	5.93e-05	0.00063	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CCNE1—brain cancer	5.83e-05	0.000621	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CCNE1—brain cancer	5.8e-05	0.000617	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—BSG—brain cancer	5.8e-05	0.000617	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—BRCA2—brain cancer	5.78e-05	0.000615	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—PCNA—brain cancer	5.78e-05	0.000615	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CCND1—brain cancer	5.77e-05	0.000613	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—BSG—brain cancer	5.76e-05	0.000613	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—PCNA—brain cancer	5.75e-05	0.000611	CbGpPWpGaD
Gemcitabine—POLA1—G1/S Transition—MYC—brain cancer	5.73e-05	0.000609	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—SKP2—brain cancer	5.7e-05	0.000606	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDK6—brain cancer	5.68e-05	0.000604	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—brain cancer	5.63e-05	0.000599	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CCNE1—brain cancer	5.6e-05	0.000596	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—PCNA—brain cancer	5.55e-05	0.00059	CbGpPWpGaD
Gemcitabine—TYMS—G1/S Transition—MYC—brain cancer	5.49e-05	0.000584	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—BSG—brain cancer	5.42e-05	0.000576	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—brain cancer	5.4e-05	0.000574	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	5.33e-05	0.000567	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDK6—brain cancer	5.3e-05	0.000564	CbGpPWpGaD
Gemcitabine—POLA1—S Phase—MYC—brain cancer	5.2e-05	0.000553	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—PCNA—brain cancer	5.17e-05	0.00055	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	5.16e-05	0.000549	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—PCNA—brain cancer	5.14e-05	0.000547	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—PDGFRA—brain cancer	5.13e-05	0.000546	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDK6—brain cancer	5.08e-05	0.00054	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDK4—brain cancer	5e-05	0.000532	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—IDH1—brain cancer	4.98e-05	0.00053	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDK4—brain cancer	4.97e-05	0.000528	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—PCNA—brain cancer	4.96e-05	0.000528	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—IDH1—brain cancer	4.95e-05	0.000527	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	4.94e-05	0.000526	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—MYC—brain cancer	4.83e-05	0.000514	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDK4—brain cancer	4.8e-05	0.00051	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ENO2—brain cancer	4.78e-05	0.000509	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PIK3CG—brain cancer	4.69e-05	0.000499	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—IDH1—brain cancer	4.66e-05	0.000495	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—MYC—brain cancer	4.62e-05	0.000492	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	4.56e-05	0.000485	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	4.52e-05	0.00048	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDK4—brain cancer	4.47e-05	0.000475	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP2C9—brain cancer	4.47e-05	0.000475	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CCNE1—brain cancer	4.46e-05	0.000475	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDK4—brain cancer	4.44e-05	0.000472	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	4.37e-05	0.000465	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	4.33e-05	0.00046	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDK4—brain cancer	4.29e-05	0.000456	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	4.28e-05	0.000456	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CCNE1—brain cancer	4.28e-05	0.000455	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—BRCA2—brain cancer	4.12e-05	0.000438	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	4.06e-05	0.000432	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CCNE1—brain cancer	3.99e-05	0.000425	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	3.97e-05	0.000423	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—PCNA—brain cancer	3.95e-05	0.000421	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—BRCA2—brain cancer	3.95e-05	0.00042	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ENO2—brain cancer	3.94e-05	0.000419	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ENO2—brain cancer	3.92e-05	0.000417	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CCNE1—brain cancer	3.82e-05	0.000407	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN2A—brain cancer	3.82e-05	0.000406	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	3.81e-05	0.000405	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—BSG—brain cancer	3.8e-05	0.000404	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN2A—brain cancer	3.8e-05	0.000404	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—PCNA—brain cancer	3.79e-05	0.000403	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ENO2—brain cancer	3.68e-05	0.000392	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN2A—brain cancer	3.67e-05	0.00039	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.66e-05	0.000389	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.58e-05	0.000381	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	3.55e-05	0.000378	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—PCNA—brain cancer	3.54e-05	0.000376	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.5e-05	0.000373	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	3.43e-05	0.000365	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.43e-05	0.000365	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDK4—brain cancer	3.42e-05	0.000364	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN2A—brain cancer	3.42e-05	0.000363	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN2A—brain cancer	3.39e-05	0.000361	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—PCNA—brain cancer	3.39e-05	0.00036	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN2A—brain cancer	3.28e-05	0.000349	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDK4—brain cancer	3.27e-05	0.000348	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—IDH1—brain cancer	3.27e-05	0.000347	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CCND1—brain cancer	3.23e-05	0.000343	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	3.21e-05	0.000342	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CCND1—brain cancer	3.21e-05	0.000341	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CCND1—brain cancer	3.1e-05	0.00033	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDK4—brain cancer	3.06e-05	0.000325	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3e-05	0.00032	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDK4—brain cancer	2.93e-05	0.000312	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CG—brain cancer	2.9e-05	0.000308	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CCND1—brain cancer	2.89e-05	0.000307	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.88e-05	0.000306	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CCND1—brain cancer	2.87e-05	0.000305	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	2.81e-05	0.000299	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL2—brain cancer	2.8e-05	0.000298	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CCND1—brain cancer	2.77e-05	0.000295	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—brain cancer	2.76e-05	0.000294	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	2.76e-05	0.000294	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	2.75e-05	0.000292	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	2.73e-05	0.00029	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN2A—brain cancer	2.61e-05	0.000278	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MYC—brain cancer	2.59e-05	0.000275	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ENO2—brain cancer	2.58e-05	0.000275	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MYC—brain cancer	2.57e-05	0.000274	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	2.53e-05	0.00027	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—brain cancer	2.5e-05	0.000266	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MYC—brain cancer	2.48e-05	0.000264	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	2.41e-05	0.000257	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—VEGFA—brain cancer	2.38e-05	0.000253	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN2A—brain cancer	2.34e-05	0.000249	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MYC—brain cancer	2.31e-05	0.000246	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MYC—brain cancer	2.3e-05	0.000245	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN2A—brain cancer	2.24e-05	0.000238	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MYC—brain cancer	2.22e-05	0.000236	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CCND1—brain cancer	2.21e-05	0.000235	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CG—brain cancer	2.19e-05	0.000233	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CCND1—brain cancer	2.11e-05	0.000225	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.09e-05	0.000222	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CCND1—brain cancer	1.97e-05	0.00021	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.96e-05	0.000209	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—brain cancer	1.9e-05	0.000202	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CCND1—brain cancer	1.89e-05	0.000201	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—brain cancer	1.89e-05	0.000201	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—brain cancer	1.82e-05	0.000194	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CG—brain cancer	1.81e-05	0.000192	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CG—brain cancer	1.8e-05	0.000191	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MYC—brain cancer	1.77e-05	0.000188	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MYC—brain cancer	1.7e-05	0.00018	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CG—brain cancer	1.69e-05	0.00018	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.64e-05	0.000174	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MYC—brain cancer	1.58e-05	0.000168	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.53e-05	0.000162	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MYC—brain cancer	1.52e-05	0.000161	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP2C9—brain cancer	1.38e-05	0.000147	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.35e-05	0.000143	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.33e-05	0.000142	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—brain cancer	1.3e-05	0.000138	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—brain cancer	1.25e-05	0.000133	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CG—brain cancer	1.18e-05	0.000126	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.17e-05	0.000125	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—BSG—brain cancer	1.17e-05	0.000125	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.08e-05	0.000115	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.06e-05	0.000112	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—IDH1—brain cancer	1.01e-05	0.000107	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	8.88e-06	9.45e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ENO2—brain cancer	7.96e-06	8.47e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CG—brain cancer	3.65e-06	3.89e-05	CbGpPWpGaD
